Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR
Clinical trial NCT01854034 · COMPLETED
Trial details
- NCT number
- NCT01854034
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2017-03-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.